Determination of Cancer Risk Associated with Germ Line BRCA1 Missense Variants by Functional Analysis
Marcelo A. Carvalho,
1,3Sylvia M. Marsillac,
1,4Rachel Karchin,
6Siranoush Manoukian,
7Scott Grist,
9Ramona F. Swaby,
10Turan P. Urmenyi,
4Edson Rondinelli,
4,5Rosane Silva,
4Luis Gayol,
12Lisa Baumbach,
12Rebecca Sutphen,
1,2Jennifer L. Pickard-Brzosowicz,
2Katherine L. Nathanson,
11Andrej Sali,
13David Goldgar,
14Fergus J. Couch,
15Paolo Radice,
7,8and Alvaro N.A. Monteiro
11
Risk Assessment, Detection, and Intervention Program, and
2Lifetime Cancer Screening and Prevention Center, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida;
3Centro Federal de Educac¸a˜o Tecnolo ´gica de Quı´mica;
4Laborato ´rio de Metabolismo Macromolecular Firmino Torres de Castro, Instituto de Biofı´sica Carlos Chagas Filho, and
5Departamento de Clı´nica Me´dica, Faculdade de Medicina, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil;
6Department of Biomedical Engineering, Institute of Computational Medicine, Johns Hopkins University, Baltimore, Maryland;
7Department of Experimental Oncology, Istituto Nazionale Tumori;
8Fondazione Italiana per la Ricerca sul Cancro, Institute of Molecular Oncology, Milan, Italy;
9
Department of Haematology and Genetic Pathology, Flinders University Medical Centre, Bedford Park, South Australia, Australia;
10Department of Medical Oncology, Fox Chase Cancer Center;
11Division of Medical Genetics, Department of Medicine, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania;
12The Dr. John T. Macdonald Foundation Center for Medical Genetics and Department of Pediatrics, Miller School of Medicine, University of Miami, Miami, Florida;
13